|
|
Volumn 11, Issue 2, 2001, Pages 165-168
|
|
2,2-dimethyl-4,5-diaryl-3(2H)furanone derivatives as selective cyclo-oxygenase-2 inhibitors
a
a
a
a
a
a
a
a
a
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
2,2 DIMETHYL 5 [4 (METHYLSULFONYL)PHENYL] 4 PHENYL 3(2H) FURANONE DERIVATIVE;
CELECOXIB;
CYCLOOXYGENASE 1 INHIBITOR;
CYCLOOXYGENASE 2 INHIBITOR;
NONSTEROID ANTIINFLAMMATORY AGENT;
ROFECOXIB;
UNCLASSIFIED DRUG;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANTIINFLAMMATORY ACTIVITY;
ARTICLE;
CONTROLLED STUDY;
DRUG POTENCY;
DRUG SELECTIVITY;
DRUG SYNTHESIS;
GASTROINTESTINAL TOXICITY;
NONHUMAN;
PAW EDEMA;
RAT;
ANIMALS;
ARTHRITIS, EXPERIMENTAL;
COMBINATORIAL CHEMISTRY TECHNIQUES;
CYCLOOXYGENASE 1;
CYCLOOXYGENASE 2;
CYCLOOXYGENASE 2 INHIBITORS;
CYCLOOXYGENASE INHIBITORS;
DISEASE MODELS, ANIMAL;
EDEMA;
FOOT DISEASES;
FURANS;
INHIBITORY CONCENTRATION 50;
ISOENZYMES;
MEMBRANE PROTEINS;
PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES;
RATS;
RATS, SPRAGUE-DAWLEY;
STRUCTURE-ACTIVITY RELATIONSHIP;
|
|
EID: 0035931560
PISSN: 0960894X
EISSN: None
Source Type: Journal
DOI: 10.1016/S0960-894X(00)00634-X Document Type: Article |
|
Times cited : (32)
|
|
References (21)
|
